 CARLSBAD, Calif., June 01, 2022 GLOBE NEWSWIRE -- Design Therapeutics, Inc. Nasdaq: DSGN, a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that João Siffert, M.D., president and chief executive officer, will present at the 2022 Jefferies Healthcare Conference on Wednesday, June 8, 2022, at 8:30 a.m. ET in New York City. 